3 Reasons Goldman Sachs Still Neutral On Intercept Pharma
May 31, 2016 at 08:30 AM EDT
Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) rose 10 percent in the pre-market trading after FDA approved its drug Ocaliva to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.